This study aimed to bridge this gap by developing a nomogram integrating radiomic and clinical variables to predict Napsin A expression, addressing the unmet need for non-invasive molecular phenotyping in lung adenocarcinoma. Here, NAPSA is linked to lung adenocarcinoma.